This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
3 Reasons Why Growth Investors Shouldn't Overlook Carlisle (CSL)
by Zacks Equity Research
Carlisle (CSL) could produce exceptional returns because of its solid growth attributes.
Carlisle (CSL) Q4 Earnings & Revenues Surpass Estimates
by Zacks Equity Research
Carlisle's (CSL) fourth-quarter 2021 revenues increase 39.2% year over year on account of impressive performance across its segments.
General Electric (GE) to Restructure Steam Power Portfolio
by Zacks Equity Research
General Electric (GE) decides to reshape its steam power portfolio by divesting certain businesses to the EDF Group. It expects to record non-cash charges related to the deal.
Carlisle (CSL) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Carlisle (CSL) delivered earnings and revenue surprises of 11.45% and 7.04%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
3M (MMM) Announces 0.7% Hike in Quarterly Dividend Rate
by Zacks Equity Research
3M (MMM) board hikes the quarterly dividend rate by 0.7%. The move is in sync with the company's shareholder-friendly policies.
Should You Buy Carlisle (CSL) Ahead of Earnings?
by Zacks Equity Research
Carlisle (CSL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Carlisle (CSL) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Carlisle (CSL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Honeywell (HON) Q4 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Honeywell's (HON) fourth-quarter 2021 revenues decrease 3% year over year due to lackluster performance across most of its segments.
Honeywell International Inc. (HON) Tops Q4 Earnings Estimates
by Zacks Equity Research
Honeywell International Inc. (HON) delivered earnings and revenue surprises of 0.48% and 0.97%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Honeywell (HON) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Honeywell's (HON) Q4 earnings are likely to have gained from strong UOP and advanced materials businesses. Weak defense and space business and high costs and expenses might have been spoilsports.
Will Carlisle (CSL) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Carlisle (CSL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Danaher (DHR) Tops on Q4 Earnings, Suffers From Cost Woes
by Zacks Equity Research
Danaher's (DHR) Q4 earnings reflect gains from solid segmental results and higher gross and operating margins. High costs and expenses restrict margin growth. It projects cost sales growth for 2022.
Griffon (GFF) Hunter Fan Buyout to Add Vigor to CPP Segment
by Zacks Equity Research
Griffon (GFF) completes the acquisition of Hunter Fan, now part of the CPP segment. The buyout is predicted to be immediately accretive to the company's earnings and cash flow.
Crane (CR) Beats Q4 Earnings Estimates, Gives Promising View
by Zacks Equity Research
Crane's (CR) Q4 earnings reflect gains from solid segmental performance and improved margin. It projects higher revenues and earnings for 2022 and announces shareholder rewards with a dividend hike.
3M's (MMM) Earnings and Revenues Surpass Estimates in Q4
by Zacks Equity Research
3M's (MMM) fourth-quarter 2021 net sales increase 0.3% year over year on account of impressive performance across its Health Care and Consumer segments.
General Electric (GE) Lags on Q4 Earnings, Gives Solid View
by Zacks Equity Research
General Electric's (GE) Q4 earnings reflect the impacts of supply shortages and poor segmental performance, except for Aviation, as well as lower costs and expenses. Earnings in 2022 are to grow y/y.
General Electric (GE) Partners Circle to Improve Health Outcome
by Zacks Equity Research
General Electric's (GE) 10-year partnership deal with Circle Health will likely improve patient health outcomes across the latter's network of around 50 hospitals in the United Kingdom.
Griffon (GFF) Gets Antitrust Clearance for Hunter Fan Buyout
by Zacks Equity Research
Griffon (GFF) receives HSR clearance and will soon complete the acquisition of Hunter Fan. The buyout is predicted to be immediately accretive to the company's earnings and cash flow.
General Electric (GE) Arm Wins Wind Turbine Deal From Continuum
by Zacks Equity Research
General Electric (GE) to offer 37 units of 2.7-132 onshore wind turbines to 99.9 MW Rajkot wind farm in Gujarat, India.
Carlisle (CSL) Gains From Solid Demand and Buyout Synergies
by Zacks Equity Research
Carlisle (CSL) seems a good investment option. It boasts healthy product demand, synergistic gains from buyouts, solid product offerings and a focus on product introductions.
Griffon (GFF) Highlights Importance of Hunter Fan Acquisition
by Zacks Equity Research
Griffon (GFF) reveals the pros of the proposed acquisition of Hunter Fan to shareholders. Hunter Fan's product offerings, customer base, and innovation abilities will likely boost Griffon's earnings.
Here's Why You Should Retain Caterpillar (CAT) Stock Now
by Zacks Equity Research
Solid demand, savings from cost reduction actions and positive movement in earnings estimates make Caterpillar (CAT) stock worth retaining in the portfolio.
ITT to Gain From Business Strength & Investments Amid Risks
by Zacks Equity Research
ITT stands to gain from strength in businesses, innovation investments and shareholder-friendly policies. Costs and expenses and capital expenditure witness a rise.
MARUY vs. CSL: Which Stock Is the Better Value Option?
by Zacks Equity Research
MARUY vs. CSL: Which Stock Is the Better Value Option?
General Electric (GE) Acquires BK Medical, To Buy Opus One
by Zacks Equity Research
General Electric's (GE) BK Medical acquisition is expected to boost its offerings in the ultrasound space. Also, Opus One, when acquired, will add vigor to GE Digital offerings to electric utilities.